Latest Schedule 13D activist filings

Bank of America Corporation and its affiliate have fully redeemed their Variable Rate MuniFund Term Preferred Shares in Pioneer Municipal High Income Advantage Fund, Inc., ceasing beneficial ownership.

Bank of America Corporation and its affiliate have fully divested their holdings in Pioneer Municipal High Income Advantage Fund's Variable Rate MuniFund Term Preferred Shares following a redemption by the issuer.

David Nate Breslauer has reduced his beneficial ownership in Bolt Projects Holdings, Inc. to 4.0%, falling below the 5% threshold.

TPG Inc. filed an Amendment No. 7 to its Schedule 13D, updating beneficial ownership, detailing the Peppertree Capital Management acquisition, and disclosing a significant long-term incentive award for James G. Coulter.

Frazier Life Sciences funds have updated their beneficial ownership in NewAmsterdam Pharma, detailing recent share purchases and clarifying ownership attribution.

Frazier Life Sciences funds filed an amended Schedule 13D to clarify beneficial ownership of MBX Biosciences, Inc. common stock, correcting prior attributions.

Frazier Life Sciences funds filed an amended Schedule 13D for KalVista Pharmaceuticals, Inc., clarifying beneficial ownership percentages and attribution.

Frazier Life Sciences and affiliated entities updated their beneficial ownership in Arcutis Biotherapeutics, Inc. via an Amendment No. 7 to their Schedule 13D.

Frazier Life Sciences and affiliated entities filed an amended Schedule 13D, clarifying their beneficial ownership in Phathom Pharmaceuticals, Inc. and correcting prior attributions.

Frazier Life Sciences entities and associated individuals have filed an Amendment No. 6 to their Schedule 13D for Mirum Pharmaceuticals, Inc., clarifying beneficial ownership attribution for certain funds.

Versant Venture Capital funds have reduced their beneficial ownership in LENZ Therapeutics, Inc. through recent share sales totaling over $10 million.

John R. Wilson's trust has reduced its beneficial ownership in Marker Therapeutics, Inc. to below 5% through a series of open market sales.

Activist investor Third Point LLC and Daniel S. Loeb have fully divested their 9.65% stake in Soho House & Co Inc.

Hillhouse Investment Management submits a competing proposal to acquire Smart Share Global Limited for $1.77 per ADS, challenging a lower management-led take-private offer.

CAS Investment Partners and affiliated entities have updated their beneficial ownership in Cardlytics, Inc. to 9.8% through recent transactions and distributions.

CMB.TECH NV's major shareholders, including Compagnie Maritime Belge NV, report a change in their beneficial ownership percentage to 61.6% following the merger with Golden Ocean Group Limited and the issuance of new shares.

The merger between Golden Ocean Group Limited and CMB.TECH Subsidiary has closed, resulting in the delisting of Golden Ocean shares from Nasdaq and Oslo Stock Exchange.

The merger between Golden Ocean Group Limited and CMB.TECH Subsidiary has closed, resulting in the delisting of Golden Ocean shares from Nasdaq and Oslo Stock Exchange.

Edgemode, Inc. CEO Charles Faulkner increased his beneficial ownership to 28.9% through salary conversion and option exercises.

Edgemode, Inc.'s Chief Technology Officer, Bo Niclas Adler, has increased his beneficial ownership to 64.5% of the company's common stock, primarily through a share exchange agreement.

Edgemode, Inc.'s CFO, Simon Wajcenberg, increased his beneficial ownership to 29.4% through salary conversion and option grants, aiming for control.

RYOJBABA Co., Ltd.'s Chief Financial Officer and Board Member, Satoshi Saito, has disclosed beneficial ownership of 5.69% of the company's common shares, subject to a 12-month lock-up agreement.

Ryoji Baba, CEO of RYOJBABA CO., LTD., and his wholly-owned entity, Miracle Exploration Technologies Ltd., collectively hold 71.32% of the company's common shares following a 1,000-for-1 stock split.

Paul Taylor has disclosed a 5.766% beneficial ownership stake in Edgemode, Inc., held for investment purposes.

Saba Capital Management, L.P. and its affiliates have increased their beneficial ownership in Bancroft Fund Ltd. to 5.04% through recent open market purchases.

Van Herk Investments, holding 11.6% of ProQR Therapeutics, escalated its corporate governance concerns, demanding board changes and adherence to Dutch corporate governance standards.

Osisko Development Corp. and Condire have amended their agreement to cap Condire's beneficial ownership at 9.99% following recent private placements and warrant exercises.

Soho House & Co Inc. details a definitive merger agreement with EH Parent LLC, outlining key shareholder rollover commitments and future governance.

Soho House & Co Inc. details a definitive merger agreement with EH Parent LLC, outlining key shareholder rollover commitments and future governance.

Stoic Point Capital Management and its principals have reduced their beneficial ownership in Evolv Technologies Holdings, Inc. to 3.1% of Class A Common Stock.